Pfizer Inc
NYSE: PFE
▲
33.87
+0.55
+1.65%
1 Day
-
Open
33.44
-
Previous Close
33.32
-
Volume (Avg)
28.59M (19.32M)
-
Day's Range
33.40-34.02
-
52Wk Range
28.25-37.39
-
Market Cap.
205.44B
-
Dividend Rate (Yield)
1.20 (3.54%)
-
Beta
0.86
-
Shares Outstanding
6.07B
-
P/E Ratio (EPS)
29.94 (1.13)
Top Stories
-
Gilead’s Growth Tonic Is Elusive, May Have Side Effects
The Wall Street Journal 1 hr ago -
At a Loss for Meds, Venezuela’s Mentally Ill Spiral Downward
New York Times -
UBS Reiterates Buy on Pfizer (PFE) Following a Meeting with Management
StreetInsider -
BRIEF-Pfizer completes acquisition of Medivation
Reuters -
Pfizer Staying Together, Valeant Breaking Up - A Rangeley Capital Portfolio Manager Discussion
Seeking Alpha 3 days ago -
Pfizer's 9% Decline Gives Dividend Investors Buying Opportunity
Seeking Alpha -
Fitch Affirms Ratings on Pfizer (PFE) Amid Decision to Remain Whole
StreetInsider -
Pfizer (PFE) to Stay Together as a Single Company After All
NASDAQ -
Is This Pfizer's Next Mega-Blockbuster Cancer Drug?
The Motley Fool -
Pfizer decides against split-up; more deals seen likely
Reuters -
Pfizer eschews proposal to split into two
USA Today -
Pfizer Remains Whole, but the Option to Split Could Return
New York Times -
Pfizer’s pricey non-split may only defer problem
Reuters -
Pfizer Won’t Split, Ending Years of Speculation About Drug Giant
Bloomberg -
Pfizer won't split
Reuters 5 days ago -
One Put, One Call Option To Know About for Pfizer
NASDAQ -
Pfizer Can Conquer by Not Dividing
bloomberg.com -
UPDATE: Pfizer Says 2 Divisions Will Remain Separately Managed Within Single Company
Stockhouse
